期刊文献+

全麻加胸椎旁阻滞对原发性肝癌患者术后机体免疫及肿瘤标志物影响观察 被引量:10

Effect of general anesthesia combined with thoracic paravertebral block on Postoperative Immunity and tumor markers in patients with primary liver cancer
原文传递
导出
摘要 目的原发性肝癌发生率较高,临床上多以手术治疗为主,但是患者手术过程中选择何种麻醉方法存在争议。本研究主要探讨全麻加胸椎旁阻滞在原发性肝癌患者中的应用及对机体免疫、肿瘤标志物的影响。方法选择西南医科大学附属医院2015-08-01-2017-06-30收治原发性肝癌手术患者40例为研究对象,根据麻醉方案不同分为对照组(n=20)和观察组(n=20)。对照组采用静脉全身麻醉,观察组在对照组基础上联合胸椎旁神经阻滞麻醉。采用流式细胞计数仪测定患者术前、术后7d外周血T淋巴细胞亚群水平,电化学发光法测定甲胎蛋白(AFP)、癌胚抗原(CEA)、铁蛋白(FERR)、糖类抗原199(CA199)和糖类抗原724(CA724)水平。采用直观模拟量表(visual analogue scales,VAS)对两组手术前、后不同时间点疼痛进行评估,比较两组麻醉效果及对机体免、肿瘤标志物的影响。结果观察组术后7d,CD4+和CD8+值均高于对照组,P<0.05;CD4+/CD8+值低于对照组,P<0.05。观察组术后不同时间点疼痛评分均低于对照组,P<0.05。两组手术前AFP、CEA、FERR、CA199及CA724水平比较差异无统计学意义,P>0.05;观察组手术后7d,AFP、CEA、FERR、CA199及CA724水平均低于对照组,P<0.05。观察组并发症发生率低于对照组,差异有统计学意义,P<0.05。结论全麻联合胸椎旁阻滞对原发性肝癌患者应用效果理想,有助于改善患者术后免疫及肿瘤标志物,减轻患者疼痛,值得临床推广应用。 OBJECTIVE The incidence of primary liver cancer is high, and the most of them are mainly surgical treatment. However, it is controversial to choose the anesthesia method during the operation. This study focused on the application of general anesthesia plus thoracic paravertebral block in patients with primary liver cancer and its impact on immune and tumor markers. METHODS Forty patients with primary hepatocellular carcinoma admitted to our hospital from August 2015 to June 2017 were randomly divided into control group (n=20) and observation group (n=20). The control group was treated with intravenous general anesthesia. The observation group was anesthetized with thoraco para-vertebral nerve tissue on the basis of the control group. The levels of T lymphocyte subsets in peripheral blood pre-operation and 7 days after operation were measured by flow cytometry. The levels of T lymphocyte subsets in peripheral blood were measured by electrochemiluminescence(AFP), carcinoembryonic antigen(CEA), ferritin(FERR), carbohydrate an tigen 199(CA199), and carbohydrate antigen 724(CA724) were measured. The visual analog scale(VAS) was used before and after pain at different time points to assess the effects of anesthesia and tumor indicators in the two groups. RESULTS The ratio of CD4+ and CD8+ in the observation group at 7 days after operation was significantly higher than that in the control group (P〈0.05). The ratio of CD4+/CD84 in the observation group at 7 days after operation was lower than that in the control group (P〈0.05). The AFP, CEA, FERR, CA199 and CA724 levels in the two groups had no significant difference before operation (P〉0.05). The AFP, CEA, FERR, CA199 and CA724 levels were lower than that of the control group (P〈0.05). The incidence of complications in the observation group was lower than that in the control group (P〈0.05). CONCLUSIONS The combined effect of general anesthesia and thoracic paravertebral block in patients with primary li
作者 王明全 周军 WANG Ming quan, ZHOU Jun(Department of Anesthesiology, Affiliated Hospital of Southwest Medical University ,Luzhou 646000, P. R. Chin)
出处 《中华肿瘤防治杂志》 CAS 北大核心 2018年第16期1174-1177,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 原发性肝癌 全麻 胸椎旁阻滞 机体免疫 肿瘤标志物 直观模拟量表 primary liver cancer general anesthesia thoracic paravertebral block body immunity tumor markers visual analogue scale
  • 相关文献

参考文献14

二级参考文献110

  • 1张骍,李兴福,耿智隆,王公校,殷裕雄,陈烨,方敏霞.全麻加胸椎旁阻滞和全麻加硬膜外阻滞对开胸患者血流动力学的影响[J].西北国防医学杂志,2005,26(3):222-223. 被引量:3
  • 2Xiu-Jie Wang,Shu-Lan Yuan,Yan-Rong Lu,Jie Zhang,Bo-Tao Liu,Wen-Fu Zeng,Yue-Ming He,Yu-Rui FU.Growth inhibition of high-intensity focused ultrasound on hepatic cancer in vivo[J].World Journal of Gastroenterology,2005,11(28):4317-4320. 被引量:16
  • 3Sessler DI, Ben-Eliyahu S, Mascha EJ, et al Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial. Contemp Clin Trials, 2008, 29(4): 517-526. 被引量:1
  • 4Exadaktylos AK, Buggy DJ, Moriarty DC, et al. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis?Anesthesiology, 2006,105(4): 660-664. 被引量:1
  • 5Sturgeon CM, Duffy MJ, Stenman UH, et al. National academy of clinical biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem, 2008,54(12): ell-e79. 被引量:1
  • 6Niklinski J, Furman M, Laudanski J, et al Prognosticvalue of pretreatment CEA, SCCAg and CA199 levels in sera of patients with non-small cell lung cancer. EnrJ Cancer Prev, 1992,1 (6) : 401-406. 被引量:1
  • 7Gu CD, Osaki T, Oyama T, et al. Detection of micrometastatic tumor cells in polymph nodes of patients with completely resected non small cell lung cancer: impact on recurrence and survival. Ann Surg, 2002,235(1): 133. 被引量:1
  • 8Sood AK, Bhatty R, Kamat AA, et al. Stress hormonemediated invasion of ovarian cancer cells. Clin Cancer Res, 2006,12(2); 369-375. 被引量:1
  • 9Amano H, Ito Y, Suzuki % et al. Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor metastasis. Cancer Sci, 2009, 100(12):2318-2324. 被引量:1
  • 10Micheal L, Peter D, DonalJ. Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor p in womenundergoing anesthesia and surgery for breast cancer. Anesthesiology, 2010, 113(5): 1118-1125. 被引量:1

共引文献226

同被引文献91

引证文献10

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部